Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase

Antzeko izenburuak

• Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
  nork: Jessica H Brehm, et al.
  Argitaratua: (2012-01-01)
• Selection of Mutations in the Connection and RNase H Domains of Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Increase Resistance to 3′-Azido-3′-Dideoxythymidine
  nork: Brehm, Jessica H., et al.
  Argitaratua: (2007)
• Mechanism by which a Glutamine to Leucine Substitution at Residue 509 in the Ribonuclease H Domain of HIV-1 Reverse Transcriptase Confers Zidovudine Resistance
  nork: Brehm, Jessica H., et al.
  Argitaratua: (2008)
• Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors
  nork: Brehm, Jessica H., et al.
  Argitaratua: (2012)
• N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
  nork: Soo-Huey Yap, et al.
  Argitaratua: (2007-12-01)